Enveda Therapeutics Inc.

---

AI drug-discovery firm Enveda raises $311M

 September 23, 2026 9:14:40 am

---

Enveda appoints Porter as senior VP

 April 15, 2026 7:15:46 am

---

Enveda inflammatory bowel disease drug candidate cleared for trial

 January 5, 2026 11:08:30 am

---

Enveda raises another $150M, claims unicorn status

 September 4, 2025 2:13:59 pm

---

Boulder’s Enveda closes $130M raise to bolster AI-power drug discovery platform

 November 29, 2024 7:54:52 am

---

Enveda hires Trevejo as chief medical officer

 August 2, 2024 2:53:54 pm

---

Boulder’s Enveda forms advisory panel ahead of clinical trials

 January 11, 2024 1:02:02 pm

---

Enveda Biosciences adds $51M to oversized Series B raise

 April 24, 2023 2:11:16 pm